The week's new items are highlighted in yellow
| DECEMBER 2026 | |||
Organisation | Call | Deadline | Link |
| NIH NINDS NEI NIAAA NIDA NIMH | Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) | 15 DEC 2026 | +info |
| NOVEMBER 2026 | |||
Organisation | Call | Deadline | Link |
| NIH NINDS | Translational Neural Devices (R61/R33 - Clinical Trial Optional) | 28 NOV 2026 | +info |
| NIH NINDS | Translational Neural Devices (R61/R33 - Clinical Trial Optional) | 28 NOV 2026 | +info |
| NIH NIDA | Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed) | 3 NOV 2026 | +info |
| NIH NIDA | Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed) | 3 NOV 2026 | +info |
| OCTOBER 2026 | |||
Organisation | Call | Deadline | Link |
| NIH NINDS | Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) | 20 OCT 2026 | +info |
| NIH NINDS | Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed) | 20 OCT 2026 | +info |
| NIH NINDS | Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed) | 20 OCT 2026 | +info |
| NIH/NINDS NEI/NIAAA NICHD/NIDA NIMH | Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | 20 OCT 2026 | +info |
| NIH/NINDS NEI/NIAAA NICHD/NIDA NIMH | Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | 20 OCT 2026 | +info |
| NIH NEI NIA NIAAA NIDCD NIDA NIMH | NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required) | 16 OCT 2026 | +info |
| NIH NIA NIAAA NIDA NIMH NINDS | NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) | 16 OCT 2026 | +info |
| NIH NEI | NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed) | 16 OCT 2026 | +info |
| NIH NIA | Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional) | 16 OCT 2026 | +info |
| NIH NIDA | D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional) | 16 OCT 2026 | +info |
| NIH NIDA | Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional) | 16 OCT 2026 | +info |
| NIH NIDA NIAAA | Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional) | 16 OCT 2026 | +info |
| NIH/NINDS NEI/NIAAA NICHD/NIDA NIMH | Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | 16 OCT 2026 | +info |
| NIH NIA NIVHD | New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional) | 16 OCT 2026 | +info |
| NIH NIDCD NINDS | Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed) | 16 OCT 2026 | +info |
| NIH NIMH | Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional) | 16 OCT 2026 | +info |
| NIH NIMH | Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional) | 16 OCT 2026 | +info |
| NIH NIMH | Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed) | 16 OCT 2026 | +info |
| NIH NIA | Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimer’s Disease and Related Dementias (R01 Clinical Trial Not Allowed) | 6 OCT 2026 | +info |
| NIH NIA | Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) | 5 OCT 2026 | +info |
| NIH NIA | New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional) | 5 OCT 2026 | +info |
| NIH NIMH | Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) | 5 OCT 2026 | +info |
| NIH NIMH | Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed) | 5 OCT 2026 | +info |
| NIH NIDCD NINDS | Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed) | 5 OCT 2026 | +info |
| NIH NIA NIVHD | New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional) | 5 OCT 2026 | +info |
| NIH NIMH NEI NIDA | Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed) | 5 OCT 2026 | +info |
| SEPTEMBER 2026 | |||
Organisation | Call | Deadline | Link |
| NIH NIAAA | Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) | 19 SEP 2026 | +info |
| NIH NIA | Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) | 19 SEP 2026 | +info |
| NIH NIAAA | Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) | 16 SEP 2026 | +info |
| NIH NIAAA | Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) | 16 SEP 2026 | +info |
| NIH NIAAA | Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) | 16 SEP 2026 | +info |
| NIH NIMH | Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed) | 16 SEP 2026 | +info |
| NIH NIMH | Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required) | 15 SEP 2026 | +info |
| NIH NIMH | Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required) | 15 SEP 2026 | +info |
| NIH NIMH | Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required) | 15 SEP 2026 | +info |
| NIH NIMH | Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required) | 15 SEP 2026 | +info |
| NIH NIMH | Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required) | 15 SEP 2026 | +info |
| NIH NIMH | Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required) | 15 SEP 2026 | +info |
| NIH NIMH | Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 – Clinical Trial Required) | 15 SEP 2026 | +info |
| NIH NIMH | Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required) | 15 SEP 2026 | +info |
| NIH NIDA NEI NIA NIAAA NIMH NINDS | BRAIN Initiative: Brain-Behavior Quantification and Synchronization – Transformative and Integrative Models of Behavior at the Organismal Level (U01 Clinical Trials Not Allowed) | 9 SEP 2026 | +info |
| NIH NIDA NEI NIA NIAAA NIMH NINDS | BRAIN Initiative: Brain-Behavior Quantification and Synchronization – Transformative and Integrative Models of Behavior at the Organismal Level (U01 Clinical Trial Optional) | 9 SEP 2026 | +info |
| NIH NEI NIA NIAAA NIDCD NIDA NINDS | BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional) | 9 SEP 2026 | +info |
| NIH NEI NIA NIAAA NIDCD NIDA NINDS | BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R21 Clinical Trial Optional) | 9 SEP 2026 | +info |
| NIH NIMH | Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional) | 5 SEP 2026 | +info |
| NIH NIMH | Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed) | 5 SEP 2026 | +info |
| NIH NIDCD | In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional) | 1 SEP 2026 | +info |
| NIH NIDCD | Cooperative Agreement for In Vivo High-Resolution Imaging for Inner Ear Visualization (U01 Clinical Trial Required) | 1 SEP 2026 | +info |
| AUGUST 2026 | |||
Organisation | Call | Deadline | Link |
| JULY 2026 | |||
Organisation | Call | Deadline | Link |
| NIH NINDS | Translational Neural Devices (R61/R33 - Clinical Trial Optional) | 28 JUL 2026 | +info |
| NIH NINDS | Translational Neural Devices (R61/R33 - Clinical Trial Optional) | 28 JUL 2026 | +info |
| NIH NIDA | Device Based Treatments for Substance Use Disorders (UG3/UH3 Clinical Trial Optional) | 13 JUL 2026 | +info |
| NIH NIDA | Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) | 5 JUL 2026 | +info |
| JUNE 2026 | |||
Organisation | Call | Deadline | Link |
| NIH/NINDS NEI/NIAAA NICHD/NIDA NIMH | Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | 18 JUN 2026 | +info |
| NIH/NINDS NEI/NIAAA NICHD/NIDA NIMH | Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | 18 JUN 2026 | +info |
| NIH/NINDS NEI/NIAAA NICHD/NIDA NIMH | Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | 18 JUN 2026 | +info |
| NIH NINDS | Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) | 18 JUN 2026 | +info |
| NIH NIDA | Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed) | 17 JUN 2026 | +info |
| NIH NIDA | Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed) | 17 JUN 2026 | +info |
| NIH NEI NIA NIAAA NIDCD NIDA NIMH | NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required) | 16 JUN 2026 | +info |
| NIH NIA NIAAA NIDA NIMH NINDS | NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) | 16 JUN 2026 | +info |
| NIH NEI | NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed) | 16 JUN 2026 | +info |
| NIH NIA | Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional) | 16 JUN 2026 | +info |
| NIH NIDA | D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional) | 16 JUN 2026 | +info |
| NIH NIMH | Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional) | 16 JUN 2026 | +info |
| NIH NIMH | Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional) | 16 JUN 2026 | +info |
| NIH NIMH | Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed) | 16 JUN 2026 | +info |
| BPI France | Challenge prévention : démontrer la valeur des innovations en vie réelle | 16 JUN 2026 | +info |
| NIH NIA NIVHD | New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional) | 16 JUN 2026 | +info |
| NIH NIDA NIAAA | Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional) | 16 JUN 2026 | +info |
| NIH NIDCD NINDS | Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed) | 16 JUN 2026 | +info |
| NIH NIMH NIA | Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional) | 16 JUN 2026 | +info |
| NIH NIMH | Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional) | 16 JUN 2026 | +info |
| NIH NIMH | Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed) | 16 JUN 2026 | +info |
| NIH NIE NIA NIAAA NIMH | BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) | 15 JUN 2026 | +info |
| NIH NINDS NEI NIAAA NIDA NIMH | Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) | 15 JUN 2026 | +info |
| NIH NINDSNIAAA NIDA NIMH | Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) | 15 JUN 2026 | +info |
| NIH/NINDS NEI/NIAAA NICHD/NIDA NIMH | Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) | 15 JUN 2026 | +info |
| NIH NIA | Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimer’s Disease and Related Dementias (R01 Clinical Trial Not Allowed) | 9 JUN 2026 | +info |
| NIH NIA | Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) | 5 JUN 2026 | +info |
| NIH NIA | New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional) | 5 JUN 2026 | +info |
| NIH NIMH | Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) | 5 JUN 2026 | +info |
| NIH NIMH | Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed) | 5 JUN 2026 | +info |
| NIH NIMH NIA | Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional) | 5 JUN 2026 | +info |
| NIH NIMH | Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed) | 5 JUN 2026 | +info |
| NIH NIMH | Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional) | 5 JUN 2026 | +info |
| NIH NIDCD NINDS | Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed) | 5 JUN 2026 | +info |
| NIH NIA NIVHD | New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional) | 5 JUN 2026 | +info |
| NIH NIMH NEI NIDA | Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed) | 5 JUN 2026 | +info |
| MAY 2026 | |||
Organisation | Call | Deadline | Link
|
| NIH NIA | Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) | 22 MAY 2026 | +info |
| NIH NIAAA | Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) | 17 MAY 2026 | +info |
| NIH NIAAA | Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) | 16 MAY 2026 | +info |
| NIH NIAAA | Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) | 16 MAY 2026 | +info |
| NIH NIAAA | Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) | 16 MAY 2026 | +info |
| NIH NIMH | Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional) | 16 MAY 2026 | +info |
| NIH NIAAA | Alcohol Health Services Research (R34 Clinical Trial Optional) | 16 MAY 2026 | +info |
| NIH NIAAA | Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required) | 16 MAY 2026 | +info |
| NIH NIMH | Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed) | 16 MAY 2026 | +info |
| NIH NIMH | Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required) | 15 MAY 2026 | +info |
| NIH NIMH | Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required) | 15 MAY 2026 | +info |
| NIH NIMH | Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required) | 15 MAY 2026 | +info |
| NIH NIMH | Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required) | 15 MAY 2026 | +info |
| NIH NIMH | Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required) | 15 MAY 2026 | +info |
| NIH NIMH | Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required) | 15 MAY 2026 | +info |
| NIH NIMH | Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 – Clinical Trial Required) | 15 MAY 2026 | +info |
| NIH NIMH | Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required) | 15 MAY 2026 | +info |
| NIH NIMH NEI NIA NIAAA NIDCD NIDA NINDS | BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional) | 15 MAY 2026 | +info |
| NIH NIMH NEI NIA NIAAA NIDCD NIDA NINDS | BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed) | 8 MAY 2026 | +info |
| NIH NIMH NEI NIA NIAAA NIDCD NIDA NINDS | BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed) | 8 MAY 2026 | +info |
| NIH NIAAA | Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required) | 5 MAY 2026 | +info |
| NIH NIAAA | Alcohol Health Services Research (R01 Clinical Trial Optional) | 5 MAY 2026 | +info |
| NIH NIMH | Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional) | 5 MAY 2026 | +info |
| NIH NIMH | Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional) | 5 MAY 2026 | +info |
| NIH NIMH | Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed) | 5 MAY 2026 | +info |
| NIH NIDCD | In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional) | 3 MAY 2026 | +info |
| NIH NIDCD | Cooperative Agreement for In Vivo High-Resolution Imaging for Inner Ear Visualization (U01 Clinical Trial Required) | 3 MAY 2026 | +info |
| APRIL 2026 | |||
Organisation | Call | Deadline | Link |
| MARCH 2026 | |||
Organisation | Call | Deadline | Link |
| NIH NINDS | Translational Neural Devices (R61/R33 - Clinical Trial Optional) | 28 MAR 2026 | +info |
| NIH NINDS | Translational Neural Devices (R61/R33 - Clinical Trial Optional) | 28 MAR 2026 | +info |
| FEBRUARY 2026 | |||
Organisation | Call | Deadline | Link |
| NIH/NEI NICHD/NIDA NIMH/NINDS | Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | 19 FEB 2026 | +info |
| NIH NINDS | Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) | 18 FEB 2026 | +info |
| NIH NINDS | Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed) | 18 FEB 2026 | +info |
| NIH NINDS | Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed) | 18 FEB 2026 | +info |
| NIH/NEI NICHD/NIDA NIMH/NINDS | Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | 17 FEB 2026 | +info |
| NIH/NEI NICHD/NIDA NIMH/NINDS | Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | 17 FEB 2026 | +info |
| NIH NEI NIA NIAAA NIDCD NIDA NIMH | NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required) | 16 FEB 2026 | +info |
| NIH NIA NIAAA NIDA NIMH NINDS | NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) | 16 FEB 2026 | +info |
| NIH NEI | NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed) | 16 FEB 2026 | +info |
| NIH NIA | Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional) | 16 FEB 2026 | +info |
| NIH NIDA | D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional) | 16 FEB 2026 | +info |
| NIH NIMH | Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional) | 16 FEB 2026 | +info |
| NIH NIMH | Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional) | 16 FEB 2026 | +info |
| NIH NIMH | Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed) | 16 FEB 2026 | +info |
| NIH NIMH NIA | Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional) | 16 FEB 2026 | +info |
| NIH NIMH | Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional) | 16 FEB 2026 | +info |
| NIH NIMH | Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed) | 16 FEB 2026 | +info |
| NIH NIA | Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional) | 16 FEB 2026 | +info |
| NIH NIDA | Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional) | 16 FEB 2026 | +info |
| NIH NIA NIVHD | New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional) | 16 FEB 2026 | +info |
| NIH NIDA NIAAA | Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional) | 16 FEB 2026 | +info |
| NIH NIDCD NINDS | Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed) | 16 FEB 2026 | +info |
| NIH NICHD NIDCD | Omics Phenotypes Related to Down Syndrome for the INCLUDE Project (X01 Clinical Trial Not Allowed) | 13 FEB 2026 | +info |
| NIH NIDA | Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) | 10 FEB 2026 | +info |
| NIH NIA | Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimer’s Disease and Related Dementias (R01 Clinical Trial Not Allowed) | 6 FEB 2026 | +info |
| NIH NIA | Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) | 5 FEB 2026 | +info |
| NIH NIA | New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional) | 5 FEB 2026 | +info |
| NIH NIMH | Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) | 5 FEB 2026 | +info |
| NIH NIMH | Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed) | 5 FEB 2026 | +info |
| NIH NIMH NIA | Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional) | 5 FEB 2026 | +info |
| NIH NIMH | Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed) | 5 FEB 2026 | +info |
| NIH NIMH | Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional) | 5 FEB 2026 | +info |
| NIH NIA | Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Optional) | 5 FEB 2026 | +info |
| NIH NIMH | Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional) | 5 FEB 2026 | +info |
| NIH NIMH | Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed) | 5 FEB 2026 | +info |
| NIH NIDCD NINDS | Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed) | 5 FEB 2026 | +info |
| NIH NIA NIVHD | New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional) | 5 FEB 2026 | +info |
| NIH NIMH NEI NIDA | Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed) | 5 FEB 2026 | +info |
| JANUARY 2026 | |||
Organisation | Call | Deadline | Link |
| NIH NIDA | Integrated Functional Mapping and Molecular Profiling of Cell Ensembles Encoding the Effects of Addictive Substances in Rodents (R01 Clinical Trial Not Allowed) | 23 JAN 2026 | +info |
| BPI France | Challenge prévention : démontrer la valeur des innovations en vie réelle | 20 JAN 2026 | +info |
| NIH NIA | Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) | 20 JAN 2026 | +info |
| NIH NIMH | Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required) | 19 JAN 2026 | +info |
| NIH NIMH | Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required) | 19 JAN 2026 | +info |
| NIH NIAAA | Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) | 18 JAN 2026 | +info |
| NIH NIMH | Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed) | 16 JAN 2026 | +info |
| NIH NIAAA | Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) | 16 JAN 2026 | +info |
| NIH NIMH | Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional) | 16 JAN 2026 | +info |
| NIH NIAAA | Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) | 16 JAN 2026 | +info |
| NIH NIAAA | Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) | 16 JAN 2026 | +info |
| NIH NIAAA | Alcohol Health Services Research (R34 Clinical Trial Optional) | 16 JAN 2026 | +info |
| NIH NIAAA | Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required) | 16 JAN 2026 | +info |
| NIH NIMH | Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required) | 13 JAN 2026 | +info |
| NIH NIMH | Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required) | 13 JAN 2026 | +info |
| NIH NIMH | Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required) | 13 JAN 2026 | +info |
| NIH NIMH | Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required) | 13 JAN 2026 | +info |
| NIH NIMH | Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 – Clinical Trial Required) | 13 JAN 2026 | +info |
| NIH NIMH | Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required) | 13 JAN 2026 | +info |
| NINDS | NIH SIREN Neurologic Clinical Trials (UG3/UH3 - Clinical Trial Required) | 6 JAN 2026 | +info |
| NIH NIAAA | Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required) | 5 JAN 2026 | +info |
| NIH NIAAA | Alcohol Health Services Research (R01 Clinical Trial Optional) | 5 JAN 2026 | +info |
| NIH NIMH | Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional) | 5 JAN 2026 | +info |
| NIH NIMH | Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed) | 5 JAN 2026 | +info |
| NIH NIMH | Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional) | 5 JAN 2026 | +info |